Hakkı Caner İNAN
He was born in 1987 in Istanbul. He graduated from Hacettepe University Faculty of Medicine in 2012. He completed her specialty education in Istanbul University Cerrahpaşa Faculty of Medicine, Department of Otorhinolaryngology in 2017. He completed her compulsory service at Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital Otorhinolaryngology Clinic between 2017-2020. In 2020, He started working as a lecturer doctor in the Department of Otorhinolaryngology, Bursa Uludag University Faculty of Medicine, and he still continues to work. In 2017, he successfully passed the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Board and received the Certificate of Competence. In 2019, he worked as observer at the University of Texas MD Anderson Cancer Hospital in the United States for 1 month. He was awarded the title of Fellow of the European Board of ORL-HNS (FEBORL-HNS) by being successful in the written and oral exam he also entered in 2019.
Sessions
Description: This presentation will explore the evolving role of partial laryngectomy in the treatment of T3 laryngeal cancer within the framework of contemporary organ preservation strategies. While concurrent chemoradiotherapy has become the preferred modality for many patients, particularly in an effort to preserve laryngeal function, surgical options such as partial laryngectomy remain highly relevant in selected cases. Through clinical evidence and case-based discussion, this session will highlight the indications, technical considerations, and outcomes of partial laryngectomy in the modern era.
Outcome Objectives: Understand the rationale behind organ preservation strategies in T3 laryngeal cancer and their current place in treatment guidelines. Identify the clinical and anatomical criteria that make a patient a candidate for partial laryngectomy. Compare the oncological and functional outcomes of partial laryngectomy versus non-surgical approaches such as chemoradiotherapy. Integrate multidisciplinary perspectives when evaluating treatment options for advanced laryngeal cancer.
Background: The management of T3 laryngeal cancer has significantly evolved over the past two decades, with a marked shift toward organ-preserving chemoradiotherapy protocols. While these approaches can successfully maintain the anatomical integrity of the larynx, they do not always guarantee preservation of its function and may be associated with long-term toxicity. In selected patients, partial laryngectomy offers an alternative that not only achieves local control but also provides favorable functional outcomes. However, the use of partial surgery has declined in clinical practice, often due to overgeneralization of non-surgical strategies. This presentation aims to revisit and recontextualize the role of partial laryngectomy in light of current evidence and patient-centered care considerations.
Transoral laser surgery has an important place in early stage laryngeal cancers. Preoperative endoscopic and radiological evaluation of patients is important. Especially in glottic tumors, anterior commissure involvement is a poor prognostic criterion.